Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia
Authors
Keywords
Ketamine, MAM model, Methamphetamine, Self-administration, Sprague-Dawley rats
Journal
NEUROTOXICITY RESEARCH
Volume 32, Issue 1, Pages 121-133
Publisher
Springer Nature
Online
2017-04-18
DOI
10.1007/s12640-017-9718-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential characteristics of ketamine self-administration in the olfactory bulbectomy model of depression in male rats.
- (2017) Zuzana Babinska et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
- (2017) Claudio D'Addario et al. SCHIZOPHRENIA RESEARCH
- Association of testosterone and BDNF serum levels with craving during alcohol withdrawal
- (2016) Annemarie Heberlein et al. ALCOHOL
- KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS
- (2016) Chadi G. Abdallah et al. DEPRESSION AND ANXIETY
- Glutamatergic neurotransmission in the prefrontal cortex mediates the suppressive effect of intra-prelimbic cortical infusion of BDNF on cocaine-seeking
- (2016) Bok Soon Go et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Altered Acoustic Startle Reflex, Prepulse Inhibition, and Peripheral Brain-Derived Neurotrophic Factor in Morphine Self-Administered Rats
- (2016) Bong Hyo Lee et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- BDNF – a key transducer of antidepressant effects
- (2016) Carl Björkholm et al. NEUROPHARMACOLOGY
- Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition
- (2016) Oliver H. Miller et al. NEUROPHARMACOLOGY
- The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission
- (2016) Anna Mutti et al. PSYCHOPHARMACOLOGY
- Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats
- (2016) Jana Ruda-Kucerova et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Impact of subanesthetic doses of ketamine on AMPA-mediated responses in rats: An in vivo electrophysiological study on monoaminergic and glutamatergic neurons
- (2015) Kareem S El Iskandrani et al. JOURNAL OF PSYCHOPHARMACOLOGY
- d-amphetamine withdrawal-induced decreases in brain-derived neurotrophic factor in sprague-dawley rats are reversed by treatment with ketamine
- (2015) Jasmine J.L. Fuller et al. NEUROPHARMACOLOGY
- The Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine Require AMPA Receptor Stimulation in the mPFC and Subsequent Activation of the 5-HT Neurons in the DRN
- (2015) Kenichi Fukumoto et al. NEUROPSYCHOPHARMACOLOGY
- Comorbid substance use disorders in schizophrenia: A latent class approach
- (2015) Berit Kerner PSYCHIATRY RESEARCH
- Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression
- (2015) Ji-chun Zhang et al. PSYCHOPHARMACOLOGY
- Environmental enrichment and abstinence attenuate ketamine-induced cardiac and renal toxicity
- (2015) Xingxing Li et al. Scientific Reports
- BDNF–TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms
- (2015) Q Ren et al. Translational Psychiatry
- Antidepressant mechanism of ketamine: perspective from preclinical studies
- (2015) Lisa Scheuing et al. Frontiers in Neuroscience
- Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats
- (2015) Jana Ruda-Kucerova et al. Frontiers in Psychiatry
- BDNF Release Is Required for the Behavioral Actions of Ketamine
- (2015) A. E. Lepack et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Light alcohol intake during adolescence induces alcohol addiction in a neurodevelopmental model of schizophrenia
- (2014) Jérôme Jeanblanc et al. ADDICTION BIOLOGY
- The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
- (2014) Wei Hu et al. Annals of the New York Academy of Sciences
- Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats
- (2014) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Therapeutic infusions of ketamine: Do the psychoactive effects matter?
- (2014) E. Dakwar et al. DRUG AND ALCOHOL DEPENDENCE
- Implication of NMDA receptors in behavioural sensitization to psychostimulants: A short review
- (2014) Leos Landa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Psychostimulant addiction treatment
- (2014) Karran A. Phillips et al. NEUROPHARMACOLOGY
- Schizophrenia and co-occurring substance use disorder: Reward, olfaction and clozapine
- (2014) Raquelle I. Mesholam-Gately et al. SCHIZOPHRENIA RESEARCH
- Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms
- (2014) Petra Amchova et al. Frontiers in Pharmacology
- The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers
- (2013) Elias Dakwar et al. BIOLOGICAL PSYCHIATRY
- Leading compounds for the validation of animal models of psychopathology
- (2013) Vincenzo Micale et al. CELL AND TISSUE RESEARCH
- Conflation of cocaine seeking and cocaine taking responses in IV self-administration experiments in rats: Methodological and interpretational considerations
- (2013) David C.S. Roberts et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neurocognitive endophenotypes in schizophrenia: Modulation by nicotinic receptor systems
- (2013) Kristen M. Mackowick et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
- (2013) Luli Akinfiresoye et al. PSYCHOPHARMACOLOGY
- Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat
- (2012) Neil M. Richtand et al. PSYCHOPHARMACOLOGY
- Exaggerated cue-induced reinstatement of cocaine seeking but not incubation of cocaine craving in a developmental rat model of schizophrenia
- (2012) Rose-Marie Karlsson et al. PSYCHOPHARMACOLOGY
- A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia
- (2011) Victoria C. Wing et al. Annals of the New York Academy of Sciences
- Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia
- (2011) Daniel J. Lodge et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The effects of methamphetamine self-administration on behavioural sensitization in the olfactory bulbectomy rat model of depression
- (2011) Jana Kucerova et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Methamphetamine-Associated Psychosis
- (2011) Kathleen M. Grant et al. Journal of Neuroimmune Pharmacology
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia
- (2011) K.G. Phillips et al. NEUROPHARMACOLOGY
- In vivoandex vivoevidence for ketamine-induced hyperglutamatergic activity in the cerebral cortex of the rat: Potential relevance to schizophrenia
- (2011) Sang-Young Kim et al. NMR IN BIOMEDICINE
- Glutamatergic medications for the treatment of drug and behavioral addictions
- (2011) M. Foster Olive et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Alcohol seeking and consumption in the NVHL neurodevelopmental rat model of schizophrenia
- (2010) S.A. Berg et al. BEHAVIOURAL BRAIN RESEARCH
- Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol
- (2010) Gwenaëlle Le Pen et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psychiatric comorbidity and additional abuse of drugs in maintenance treatment withl- andd,l-methadone
- (2010) Dirk Wedekind et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Prevalence of alcohol use disorders in schizophrenia - a systematic review and meta-analysis
- (2009) J. Koskinen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia
- (2009) Daniel J. Lodge et al. BEHAVIOURAL BRAIN RESEARCH
- Gestational treatment with methylazoxymethanol (MAM) that disrupts hippocampal-dependent memory does not alter behavioural response to cocaine
- (2009) Robert E. Featherstone et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia
- (2008) S BERG et al. NEUROPHARMACOLOGY
- Tiagabine Treatment is Associated with Neurochemical, Immune and Behavioural Alterations in the Olfactory Bulbectomized Rat Model of Depression
- (2008) J. Pistovcakova et al. PHARMACOPSYCHIATRY
- Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia
- (2008) Anne Marie Brady et al. PSYCHOPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started